BioCryst announced that the Food and Drug Administration (FDA) has approved Rapivab (peramivir) injection for the treatment of acute uncomplicated influenza in patients ≥18 years who have been symptomatic for no more than two days.
Bisphosphonates may lower the risk of endometrial cancer, new research suggests.
Many states have been slow to adopt preparticipation physical evaluation-fourth edition (PPE-4) recommendations, with more than half of states requiring or recommending use of outdated or unidentifiable forms.
Melanoma may be dermoscopically indistinguishable from Spitz nevi, according to a new study.
Psoriasis may be associated with a higher risk of developing chronic kidney disease (CKD) and glomerulonephritis (GN).
Older women are more likely to restrict their driving activity more than older men, regardless of physical health or cognitive status.
Jazz announced that the Food and Drug Administration has approved the intravenous (IV) administration of Erwinaze (asparaginase Erwinia chrysantheum).
Cubist announced that the Food and Drug Administration (FDA) has approved Zerbaxa (ceftolozane/tazobactam) Injection for the treatment of adults with complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI) caused by susceptible Gram-negative bacteria.
All children should have an eye exam between the ages of 3-6, preferably every year, according to new vision-screening recommendations for preschool-aged children.
Simple tips can help physicians and their spouses maintain marital happiness, according to a new article.
- Over 50 FDA-Approved Meds Could Treat Ebola Infection
- Pharmacy Employees Arrested, Charged in Meningitis Outbreak
- How Effective Are Neuraminidase Inhibitors in Containing Flu?
- Ondansetron, Tramadol Drug Interaction Identified
- Pain Management in Patients with IBD: Individualizing Treatment Approaches